11 Dec 2017
Monday 11th December 2017
Leading biotech Immunocore expands to The Oxford Science Park
Oxford, UK, December 11 2017 – Immunocore Limited, the world’s leading TCR company focused on delivering first-in-class biological therapies that transform lives, has taken laboratory and office space at The Oxford Science Park. In its new premises on the Park, Immunocore will be focused on the development of immunotherapies for infectious diseases,... Read more